Effect of selected terpenoids on antibiotic potentiation and eradication of Staphylococcus aureus biofilms – a structure activity relationship study

2020 ◽  
Author(s):  
Anabela Borges ◽  
Ana Catarina Alves ◽  
Manuel Simões

<p>Research on the discovery of new drugs to treat bacterial biofilm infections has been a priority for biomedical and scientific communities. Actually, the sessile mode of growth accounts for more than 80% of human bacterial infections and displays increased resistance to antibiotics. To date, there are no drugs with total efficacy against biofilms and the treatment failure is a recurrent clinical situation. This lack of alternatives boosted up again the exploration of the pharmacological properties of health-promoting agents from natural origin. In this connection, the potential of phytotherapeutic agents for the treatment/prevention of complex infectious diseases, such as those that involve biofilm formation has been intensified[1]. In view of that, the main aim of the present study was to evaluate the activity of four phytochemicals bellowing to terpenoids class [cis-6-nonen-1-ol (CIS), citronellic acid (CITACID), citronellol (CITRO) and 3-7-dimethyl-1-octanol (3,7DOC)] against <em>Staphylococcus aureus</em>, both in planktonic and sessile state. Firstly, the minimum inhibitory and bactericidal concentrations (MIC and MBC) were determined by the broth microdilution method and culturability on plate count agar, respectively. Then, the potential of each terpenoid as resistance modifying agent was assessed by the disc diffusion method, using antibiotics from different classes. Besides, its potential to eradicate pre-formed S. aureus biofilms (24-h old) was performed using a microtiter plate assay and characterized in terms of biofilm mass removal (crystal violet staining), metabolic activity reduction (alamar blue staining) and culturability (colony forming units - CFU - counts). Considering that the selected terpenoids are chemical structurally related, i.e. present a similar backbone and differ only on the functional groups location, a structure activity relationship (SAR) analysis was also established. Both CITO and 3,7DOC presented the lowest MIC value (200 μg/mL) followed by CIS (400 μg/mL) and CITACID (1000 μg/mL). The MBC was found to be 1000 µg/mL with CIS, 2000 µg/mL with CITACID and > 2000 µg/mL (the maximum concentration tested) with CITO/3,7DOC. Apparently, the hydrophobicity of the molecules appear to affect positively its inhibitory proprieties – molecules with higher hydrophobicity presented lower MIC values. Moreover, it seems that the hydroxyl and methyl functional groups play the major influence on the antimicrobial properties. Indeed, CITO and 3,7DOC presented the higher hydrophobicity values and both had hydroxyl and methyl functional groups, possessing the lowest MIC value. Independently of the terpenoid tested, all combinations (terpenoid-antibiotic) resulted in a potentiation effect. Regarding biofilm eradication, although no biomass removal was observed, metabolic activity reductions from 25% (CIS at 5×MIC) up to 44% (CITACID at 10×MIC) and total loss of culturability (CITACID at 10×MIC; 6-log CFU/cm<sup>2</sup> reduction) was found. These effects were found to be dose dependent. Overall, the results obtained suggest that all the tested terpenoids might be interesting antibiotic adjuvants and emphasize the use of CITACID for biofilm cells inactivation. The results obtained are promising since the terpenoids studied are natural occurring flavoring ingredients, generally recognized as safe by the FDA, which are usually applied as food additives for human consumption.</p> <p><strong>References</strong><strong>: </strong>[1] A.Borges, A.Abreu, C.Dias, M.Saavedra, F.Borges, M.Simões, Molecules 21(2016)877.</p>

Molecules ◽  
2020 ◽  
Vol 25 (3) ◽  
pp. 479 ◽  
Author(s):  
Der-Yen Lee ◽  
Yu-Chi Hou ◽  
Jai-Sing Yang ◽  
Hui-Yi Lin ◽  
Tsu-Yuan Chang ◽  
...  

Compound 1 is a curcumin di-O-2,2-bis(hydroxymethyl)propionate that shows significant in vitro and in vivo inhibitory activity against MDA-MB-231 cells with eight to ten-fold higher potency than curcumin. Here, we modified the α-position (C-4 position) of the central 1,3-diketone moiety of 1 with polar or nonpolar functional groups to afford a series of 4,4-disubstituted curcuminoid 2,2-bis(hydroxymethyl)propionate derivatives and evaluated their anticancer activities. A clear structure–activity relationship of compound 1 derivatives focusing on the functional groups at the C-4 position was established based on their anti-proliferative effects against the MDA-MB-231 and HCT-116 cell lines. Compounds 2–6 are 4,4-dimethylated, 4,4-diethylated, 4,4-dibenzylated, 4,4-dipropargylated and 4,4-diallylated compound 1, respectively. Compounds 2m–6m, the ester hydrolysis products of compounds 2–6, respectively, were synthesized and assessed for anticancer activity. Among all compound 1 derivatives, compound 2 emerged as a potential chemotherapeutic agent for colon cancer due to the promising in vivo anti-proliferative activities of 2 (IC50 = 3.10 ± 0.29 μM) and its ester hydrolysis product 2m (IC50 = 2.17 ± 0.16 μM) against HCT-116. The preliminary pharmacokinetic evaluation of 2 implied that 2 and 2m are main contributors to the in vivo efficacy. Compound 2 was further evaluated in an animal study using HCT-116 colon tumor xenograft bearing nude mice. The results revealed a dose-dependent efficacy that led to tumor volume reductions of 27%, 45%, and 60% at 50, 100, and 150 mg/kg doses, respectively. The established structure–activity relationship and pharmacokinetic outcomes of 2 is the guidance for future development of 4,4-disubstituted curcuminoid 2,2-bis(hydroxymethyl)- propionate derivatives as anticancer drug candidates.


2019 ◽  
Vol 17 (2) ◽  
pp. 93-98
Author(s):  
Nidaa Rasheed ◽  
Natalie J. Galant ◽  
Imre G. Csizmadia

<P>Introduction: Staph infection, caused by a bacterium known as Staphylococcus aureus, results in a range of diseases from cellulitis to meningitis. Dicoumarol compounds are now emerging as new anti-Staph infection agents as they possess a different chemical structure than compounds used in previous treatments, in order to combat antibiotic-resistant strains. However, it is unclear how such chemical modulations to the dicoumarol backbone structure achieve higher drug performance. Methods: The following review analyzed various quantitative structure-activity relationship (QSAR) studies on dicoumarol compounds and compared them against the corresponding minimum inhibitory concentration and binding affinity values. Results: Compared to the antimicrobial activity, the dicoumarol derivatives with electron withdrawing substituents, CL, NO2, and CF3 showed an inverse correlation; whereas, the opposite was observed with electron donating compounds such as OH, OMe, and amine groups. Based on the interactions of dicoumarol at the active site, an “aromatic donor-acceptor” relationship was proposed as the method of action for this drug. Furthermore, substituent positioning on the benzene ring was found to exert a greater effect on the binding affinity, speculating that the mechanism of action is two characteristics based, needing, both, the proper aromatic pi-pi interaction for stabilization and direct binding to the OH group in the Tyrosine residue, affected by the steric hindrance. Conclusion: This foundational review can enhance productivity sought by the pharmaceutical agency to use combinational chemistry to increase the efficiency to discover new hits in the synthesis of dicoumarol drugs against Staph infection.</P>


MedChemComm ◽  
2018 ◽  
Vol 9 (12) ◽  
pp. 2008-2016
Author(s):  
Enrico Speri ◽  
Jennifer Fishovitz ◽  
Shahriar Mobashery

MIC of oxacillin against S. aureus (MRSA252 strain) reduced from 256 μg mL−1 to 2 μg mL−1.


2009 ◽  
Vol 17 (20) ◽  
pp. 7174-7185 ◽  
Author(s):  
Nuttee Suree ◽  
Sung Wook Yi ◽  
William Thieu ◽  
Melanie Marohn ◽  
Robert Damoiseaux ◽  
...  

2010 ◽  
Vol 45 (9) ◽  
pp. 3752-3761 ◽  
Author(s):  
Bala Chandra Chenna ◽  
Jason R. King ◽  
Bidhan A. Shinkre ◽  
Amanda L. Glover ◽  
Aaron L. Lucius ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document